IP Verse

Crystalline Forms Of Trisodium Supramolecular Complex Comprising Valsartan And Ahu-377 And Methods Thereof

Patent No. EP3229799 (titled "Crystalline Forms Of Trisodium Supramolecular Complex Comprising Valsartan And Ahu-377 And Methods Thereof") was filed by Crystal Pharmatech on Dec 8, 2015. The application was issued on Oct 17, 2018.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
D YOUNGJul 17, 2019D YOUNG

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3229799

CRYSTAL PHARMATECH
Application Number
EP15843405A
Filing Date
Dec 8, 2015
Status
Revoked
Dec 9, 2024
Publication Date
Oct 17, 2018
External Links
Slate, Register , Google Patents